Revenue Performance - Total revenue for the quarter ended December 31, 2025, increased by 23% compared to the same quarter in 2024, driven by a 16% increase in product sales and a 335% increase in contract research and development revenue [60]. - Contract research and development revenue represented 7.2% of total revenue for the quarter ended December 31, 2025, compared to 2.0% in the prior-year quarter [60]. Gross Margin and Expenses - Gross margin for the third quarter of fiscal 2026 was 79% of revenue, down from 84% in the prior-year quarter, attributed to a less profitable product mix and increased distributor sales [61]. - Total expenses decreased by 12% for the third quarter of fiscal 2026, with research and development expenses down by 9% and selling, general, and administrative expenses down by 19% [62]. Net Income and Tax Rate - Net income for the first nine months of fiscal 2026 decreased by 8% to $10.3 million, or $2.12 per diluted share, primarily due to decreased gross margin and increased effective tax rate [71]. - The effective tax rate increased to 20% for the third quarter of fiscal 2026 from 15% in the prior-year quarter, primarily due to unfavorable non-cash impacts of tax law changes [64]. - The company expects a full-year tax rate of 16% to 17% for fiscal 2026, factoring in anticipated advanced manufacturing investment tax credits [65]. Cash Position and Dividends - Cash and cash equivalents were $3,408,531 as of December 31, 2025, a decrease of $4,628,033 from March 31, 2025, due to net cash used in investing and financing activities [73]. - Cash dividends paid to shareholders during the first nine months of fiscal 2026 totaled $14,511,498, with an additional dividend of $1.00 per share announced for payment on February 27, 2026 [79]. Other Income - Interest income decreased by 3% due to a reduction in the marketable securities portfolio, while other income decreased significantly by $135,057 [63].

Financial Performance - Knight-Swift reported a fourth quarter 2025 net loss of $6.8 million, with an Adjusted Net Income of $50.9 million, compared to a net income of $69.5 million in Q4 2024[1][3] - Consolidated total revenue for Q4 2025 was $1.9 billion, a 0.4% decrease from Q4 2024, while Adjusted Operating Income decreased by 5.3% year-over-year to $100.6 million[2][3] - Operating income for Q4 2025 decreased to $26,457, down 66.0% from $77,953 in Q4 2024[38] - The company reported a comprehensive loss of $7,329 in Q4 2025 compared to a comprehensive income of $68,887 in Q4 2024[38] - Total revenue for Q4 2025 was $1,856,330, a slight decrease from $1,864,281 in Q4 2024, while year-to-date revenue increased to $7,469,689 from $7,410,078[46] - Adjusted Operating Income for Q4 2025 was $100,552, down from $106,133 in Q4 2024, with year-to-date Adjusted Operating Income rising to $396,845 from $347,867[46] - Adjusted EPS for Q4 2025 was $0.31, compared to $0.36 in Q4 2024, while year-to-date Adjusted EPS increased to $1.26 from $1.06[48] Segment Performance - The Truckload segment's revenue, excluding fuel surcharge, decreased by 2.4% year-over-year, with an Adjusted Operating Ratio of 92.9%, reflecting a 330 basis point improvement over Q3 2025[2][11] - LTL segment revenue, excluding fuel surcharge, increased by 7.0% year-over-year, driven by a 2.1% increase in shipments per day and a 5.0% increase in revenue per hundredweight[2][15] - The Logistics segment experienced a 4.8% decrease in revenue year-over-year, with an Adjusted Operating Ratio of 95.8%, a 210 basis point decline from the previous year[2][19] - Intermodal segment revenue decreased by 3.4% year-over-year to $95,663, with an operating loss improved to approximately breakeven, reflecting a 2.8% increase in revenue per load[20] - Truckload segment total revenue for Q4 2025 was $1,221,814, a decrease of 2.2% from $1,249,533 in Q4 2024[52] - LTL segment total revenue increased by 7.2% to $344,752 in Q4 2025 from $321,535 in Q4 2024[55] - Logistics segment revenue for Q4 2025 was $159,971, down 4.8% from $167,991 in Q4 2024[58] Cash Flow and Liquidity - Net cash provided by operating activities for the year ended December 31, 2025, was $1,266,647, an increase of $467,584 compared to 2024[23] - Free Cash Flow for the year ended December 31, 2025, was $763.2 million, supported by $1.3 billion in operating cash flows[25] - As of December 31, 2025, the company had $1.1 billion in unrestricted cash and available liquidity, with a net debt of $2.1 billion[25] - Free cash flow for the year-to-date period ending December 31, 2025, was $763,228, reflecting strong operational cash flows[61] Tax and Impairment - The effective tax rate on GAAP results for Q4 2025 was 21.6%, up from 13.4% in Q4 2024, indicating increased tax liabilities[4][9] - Knight-Swift combined its Abilene truckload brand into the Swift business, resulting in $52.9 million of non-cash impairment charges[1][4] - The company reported impairments of $52,891 in Q4 2025, significantly higher than $8,145 in Q4 2024, indicating potential challenges in asset valuation[47] Future Outlook - The company plans to focus on cost control, service quality, and expanding its network to drive future growth opportunities[5][6] - Expected net cash capital expenditures for full-year 2026 are projected to be between $625 million and $675 million, primarily for replacements and investments in technology[26] - Adjusted EPS guidance for the first quarter of 2026 is expected to range from $0.28 to $0.32, assuming stable market conditions[28] - Operating income for All Other Segments, excluding intangible asset amortization, is projected to be between $22 million and $26 million in the first quarter[29] - The company anticipates a gain on sale of operating assets in the range of $7 million to $12 million in the first quarter[33] - The effective tax rate on adjusted income before taxes is expected to be approximately 25% to 26% for the first quarter and for the full year 2026[33] Operational Metrics - Average revenue per tractor in the Truckload segment increased by 2.3% to $50,893 in Q4 2025 from $49,726 in Q4 2024[41] - Shipments per day in the LTL segment increased by 2.1% to 22,340 in Q4 2025 compared to 21,870 in Q4 2024[41] - Average length of haul in the LTL segment increased by 12.4% to 680 miles in Q4 2025 from 605 miles in Q4 2024[41] - The LTL tractor fleet included 649 tractors in Q4 2025, up from 638 in Q4 2024, while the LTL trailer fleet increased to 1,227 from 1,009 in the same period[43] Operational Efficiency - The operating ratio for Q4 2025 was 98.6%, compared to 95.8% in Q4 2024, indicating a decline in operational efficiency[46] - The adjusted operating ratio for the Truckload segment improved to 92.9% in Q4 2025 from 92.2% in Q4 2024[52] - The adjusted operating ratio for the LTL segment was 95.1% in Q4 2025, compared to 94.5% in Q4 2024[55] - Adjusted operating income for the Truckload segment in Q4 2025 was $76,739, down 10.7% from $85,969 in Q4 2024[52] - Adjusted operating income for the LTL segment was $14,490 in Q4 2025, a decrease of 4.8% compared to $15,216 in Q4 2024[55] - Adjusted operating income for the Logistics segment decreased to $6,696 in Q4 2025 from $10,560 in Q4 2024[58] Non-GAAP Measures - The company plans to continue focusing on non-GAAP financial measures to provide a clearer picture of core operating performance, despite the limitations of these measures[45]

News Release For Immediate Release: For More Information, Contact: January 21, 2026 Katie Doyle 336-286-8741 First Bancorp Reports Fourth Quarter and Full Year Results | Fourth Quarter | 2025 | Financial | Data | | | | --- | --- | --- | --- | --- | --- | | (Dollars in 000s, | | | | | | | except per share | | | | | | | data) | Q4-2025 | | Q3-2025 | | Q4-2024 | | Summary Income Statement | | | | | | | Total interest | | | | | | | income | $ 143,634 | | $ 144,200 | | $ 132,395 | | Total interest | | | | | | | ...

Financial Performance - Fourth quarter 2025 net income was $28.8 million, an increase of $18.9 million from the third quarter of 2025, and an increase of $9.7 million from the fourth quarter of 2024[1]. - Adjusted net income for the fourth quarter of 2025 was $30.8 million, up $2.4 million from the third quarter of 2025, and up $10.8 million from the fourth quarter of 2024[2]. - Net income for the year ended December 31, 2025, was $80,310,000, down from $85,264,000 in 2024, a decrease of 5.6%[59]. - Basic earnings per share for Q4 2025 was $0.55, compared to $0.42 in Q4 2024, an increase of 30.9%[59]. - Adjusted net income (non-GAAP) for Q4 2025 was $30,778 million, compared to $19,966 million in Q4 2024, reflecting a growth of 54%[64]. Income and Expenses - Net interest and dividend income was $83.1 million for the fourth quarter of 2025, reflecting a 0.3% increase from the third quarter of 2025 and a 34.9% increase from the fourth quarter of 2024[6]. - Noninterest income decreased by $955,000, or 7.3%, to $12.2 million in the fourth quarter of 2025 compared to the third quarter of 2025[6]. - Noninterest expense was $52.9 million for the fourth quarter of 2025, a decrease of $10.2 million, or 16.2%, from the third quarter of 2025[6]. - Total noninterest expense for Q4 2025 was $52,935 million, compared to $44,322 million in Q4 2024, marking an increase of 19%[63]. Credit and Loans - The provision for credit losses was $3.0 million in the fourth quarter of 2025, down from $19.7 million in the third quarter of 2025[6]. - Nonperforming loans totaled $52.8 million at December 31, 2025, representing 1.0% of total loans, up from 0.8% a year earlier[12]. - Total loans were $5.25 billion at December 31, 2025, a decrease of $12.4 million from September 30, 2025, but an increase of $1.27 billion from December 31, 2024, primarily due to the acquisition of Bancorp Financial[12]. - The allowance for credit losses on loans was $72.301 million as of December 31, 2025, maintaining a ratio of 1.4% to total loans, consistent with September 30, 2025[39][40]. Assets and Equity - Total assets increased to $6,902,675,000 as of December 31, 2025, up from $5,649,377,000 in 2024, representing a growth of 22.2%[57]. - Total stockholders' equity increased to $883,986 million in Q4 2025 from $849,998 million in Q3 2025, a rise of 4.00%[61]. - Retained earnings grew to $526,910 million in Q4 2025, up from $500,075 million in Q3 2025, reflecting an increase of 5.36%[61]. Dividends and Shareholder Returns - The company declared a cash dividend of $0.07 per share, payable on February 9, 2026[6]. - The company declared dividends of $0.25 per share for the year, up from $0.21 in 2024, reflecting a 19% increase[59]. Market and Strategic Position - The company plans to continue strategically buying and selling securities as opportunities arise, reflecting a proactive approach to managing its investment portfolio[12]. - The company recorded a day one purchase accounting credit mark of $17.5 million related to the acquisition in the third quarter of 2025[39]. Future Outlook - The company plans to discuss its fourth quarter 2025 financial results in a conference call scheduled for January 22, 2026[53].

Compensation and Benefits - Executive's base salary during the Transition Period will remain unchanged, and he will be eligible for a bonus under the Company's 2025 bonus plan[6] - Executive will receive a total severance payment of $1,102,500, equivalent to eighteen months of his base salary, paid in equal installments[11] - Executive's annual target bonus for 2026 is set at $918,750, with a prorated amount based on the number of days employed in 2026[12] - The Company will cover COBRA premiums for Executive and eligible dependents for up to eighteen months after the Employment End Date[13] - Executive will vest in 200,891 time-based RSUs if he remains employed through the Planned Transition Date[14] - Two-thirds of any PSUs granted to Executive on April 2, 2025, will remain eligible to vest if they become "Economic ROA Eligible Units"[15] - Executive will serve as a strategic advisor after the Transition Period, receiving a monthly fee of $61,250 until July 3, 2026[8] Transition Agreement - The Transition Agreement allows for an orderly transition of Executive's duties, with a Planned Transition Date set for April 3, 2026[3] - Executive acknowledges that the Transition Agreement will become effective on the date it has been signed by all Parties[32] - The Company agrees to provide the Executive with Severance in consideration of the Executive's execution and non-revocation of the Agreement[43] - Executive represents that the Company and Parent have paid or provided all salary, wages, bonuses, and other benefits due to the Executive[51] - Executive's health insurance benefits shall cease on the Separation Date, with the option to continue under COBRA[52] - The Transition Agreement represents the entire agreement between the Parties concerning the subject matter and supersedes any prior agreements[29] Legal and Arbitration - Any disputes arising out of the terms of the Agreement shall be subject to arbitration under the Federal Arbitration Act[54] - The arbitration must be completed within twelve months of the initial demand for arbitration[55] - The prevailing party in any arbitration is entitled to recover attorneys' fees and costs[67] - The agreement represents the entire understanding between the parties and supersedes all prior agreements[59] - The agreement is governed by the laws of the State of California[68] - The agreement will become effective on the eighth day after the Executive signs it, provided it has not been revoked[69] - The parties agree to waive their right to have any dispute resolved in a court of law[55] Confidentiality and Compliance - Executive agrees to take reasonable precautions to prevent unauthorized use or disclosure of Company trade secrets[7] - Executive certifies the return of all Company and Parent property and information[56] - Any material breach of the agreement allows the Company to recover consideration provided to the Executive[57] - Executive acknowledges that they executed the agreement voluntarily and with understanding of its terms[73] - Executive has no pending or future lawsuits against the Company or any of the Releasees[53] - Executive's resignation from the Board is not due to any disagreement with the Company[7] - The Company will use reasonable best efforts to ensure any successor assumes and agrees to perform the Agreement[35] - The Company will use reasonable best efforts to ensure any successor assumes the agreement[71]

Financial Performance - TrustCo reported a net income of $61.1 million for the year 2025, with a total shareholder return that was three times that of peers[1]. - Q4 2025 net income was $15.6 million, a 38.0% increase from $11.3 million in Q4 2024, with diluted earnings per share rising to $0.85 from $0.59[3]. - Net income for the year ended December 31, 2025, was $61,137, representing a 25.2% increase from $48,833 in 2024[14]. - Basic net income per common share increased to $3.26 in 2025 from $2.57 in 2024, a rise of 26.9%[19]. Interest Income and Margin - For Q4 2025, net interest income increased by 12.4% year-over-year to $43.7 million, driven by asset repricing and effective interest expense management[2]. - The net interest margin for Q4 2025 expanded to 2.82%, up 22 basis points from 2.60% in Q4 2024[3]. - Total interest income rose to $259,416,000 in 2025, compared to $243,316,000 in 2024, marking an increase of 6.6%[18]. - Net interest income after provision for credit losses was $167,373,000, up from $149,939,000, reflecting a growth of 11.6%[18]. Asset and Deposit Growth - Average loans increased by $126.8 million, or 2.5%, in Q4 2025 compared to the same period in 2024, reflecting strong borrower confidence[6]. - Average deposits rose by $208.0 million, or 3.9%, in Q4 2025, primarily due to increases in time deposits and interest-bearing accounts[6]. - Total assets reached $6,440,700,000 as of December 31, 2025, an increase from $6,238,744,000 in 2024, indicating a growth of 3.2%[20]. - Total deposits increased to $5,557,417,000 in 2025, compared to $5,490,314,000 in 2024, showing a growth of 1.2%[20]. Noninterest Income and Expenses - Noninterest income for Q4 2025 was $4,430, slightly up from $4,409 in Q4 2024[12]. - Total noninterest expenses for Q4 2025 decreased to $26,710 from $28,165 in Q4 2024, a reduction of 5.2%[12]. - Noninterest income decreased to $18,945,000 in 2025 from $19,834,000 in 2024, a decline of 4.5%[18]. - Total noninterest expenses slightly decreased to $105,504,000 in 2025 from $105,727,000 in 2024, a reduction of 0.2%[18]. Credit Quality and Provisions - The allowance for credit losses on loans was $52.2 million as of December 31, 2025, with a ratio of 0.99% to total loans, indicating stable asset quality[8]. - Nonperforming loans (NPLs) increased to $20.7 million, or 0.39% of total loans, as of December 31, 2025, reflecting a modest rise in credit risk[8]. - The provision for credit losses for the year ended December 31, 2025, was $1,600, down from $2,000 in 2024[14]. - The coverage ratio improved to 252.5% from 280.8% in the previous quarter, reflecting a decrease in the ability to cover nonperforming loans[23]. Shareholder Equity and Stock Performance - TrustCo repurchased 1 million shares, or 5.3%, of its common stock in 2025, with an additional 2 million shares authorized for repurchase in 2026[7]. - TrustCo's book value per share increased to $38.08 as of December 31, 2025, up 7.1% from $35.56 a year earlier[7]. - The market price per share at the end of Q4 2025 was $41.33, compared to $33.31 at the end of Q4 2024[12]. - Total shareholders' equity as of December 31, 2025, was $686,589,000, a slight decrease from $692,013,000 in 2024[21].

Financial Performance - Net income for the six months ended December 31, 2025, was $19.2 million, a record high, compared to $13.8 million for the same period in 2024, representing a 39.3% increase[2][4] - Pre-provision net income increased by $5.7 million, or 38.7%, to $20.6 million for the six months ended December 31, 2025, compared to $14.9 million for the same period in 2024[7] - Net interest income increased by $9.4 million to $36.6 million for the six months ended December 31, 2025, from $27.2 million for the same period in 2024[8] - Net income for the six months ended December 31, 2025, was $19.2 million, compared to $13.8 million for the same period in 2024, reflecting a significant year-over-year growth[25] - Basic and diluted earnings per share (EPS) increased to $1.13 for the six months ended December 31, 2025, compared to $0.81 for the same period in 2024[25] - Net income (GAAP) for the six months ended December 31, 2025, was $19,162 thousand, an increase of 39.9% from $13,751 thousand in the same period of 2024[33] Asset and Loan Growth - Total assets reached $3.1 billion at December 31, 2025, marking a new record high for the company[4][6] - Total assets increased by $106.4 million, or 3.5%, to $3.1 billion at December 31, 2025, compared to $3.0 billion at June 30, 2025[16] - Net loans amounted to $1.7 billion at December 31, 2025, also a record high for the company[4][6] - Net loans receivable rose by $58.6 million, or 3.6%, to $1.7 billion at December 31, 2025, driven by growth in commercial real estate loans, commercial loans, and home equity loans[18] - Loans receivable increased to $1,687,184 thousand as of December 31, 2025, compared to $1,627,406 thousand at June 30, 2025, reflecting a growth of 3.7%[29] Income and Expense Analysis - Noninterest income decreased by $470,000, or 6.2%, to $7.1 million for the six months ended December 31, 2025, compared to $7.6 million for the same period in 2024[15] - Noninterest expense increased by $1.6 million, or 8.4%, to $20.5 million for the six months ended December 31, 2025, compared to $18.9 million for the same period in 2024[15] - The efficiency ratio improved to 46.93% for the six months ended December 31, 2025, down from 54.39% in the same period of 2024[25] Tax and Equity - The effective tax rate was 10.9% for the six months ended December 31, 2025, compared to 6.9% for the same period in 2024, primarily due to higher pre-tax income[13] - Shareholders' equity increased to $258.3 million at December 31, 2025, primarily due to net income of $19.2 million and a decrease in accumulated other comprehensive loss[18] Recognition and Awards - The company was recognized as a top-performing bank in Piper Sandler's Class of 2025 Bank & Thrift Small-Cap All Stars, ranking 9th out of 24 banks[5] Credit Losses - The allowance for credit losses on loans increased by $1.2 million, or 5.9%, to $21.3 million at December 31, 2025, reflecting an increase in loan volume[18] - The allowance for credit losses on loans was $21,334 thousand as of December 31, 2025, compared to $20,146 thousand at June 30, 2025[29] Deposits - Deposits remained stable at $2.6 billion as of December 31, 2025, with a notable increase in NOW deposits by $48.1 million, or 2.5%[18] - Total deposits reached $2,641,040 thousand as of December 31, 2025, slightly up from $2,639,835 thousand at June 30, 2025[29] Forward-Looking Statements - The Company cautions that forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those anticipated[19] Interest Margin - Net interest margin on a fully taxable-equivalent basis (non-GAAP) improved to 2.83% for the three months ended December 31, 2025, compared to 2.31% in the same period of 2024[31]

Graphic Exhibit 99.1 NEWS - FOR IMMEDIATE RELEASE NYSE American: GORO GOLD RESOURCE CORPORATION ANNOUNCES STRONG PRELIMINARY YEAR-END RESULTS, HIGHLIGHTING OPERATIONAL TURNAROUND Denver, Colorado – January 20, 2026 – Gold Resource Corporation (NYSE American: GORO) (the "Company") is pleased to announce preliminary fourth quarter production results from its Don David Gold Mine that are a significant improvement from previous quarters and represents 45% of the full-year production for 2025. The net result is ...

Financial Performance - Consolidated revenues for the three months ended December 31, 2025, were Rs. 87,268 million, a 4% increase from Rs. 83,586 million in the same period of 2024[227]. - Gross profit for the same period was Rs. 46,806 million, representing 53.6% of revenues, down from Rs. 49,052 million or 58.7% of revenues in the previous year[243]. - Profit before tax for Q4 2025 was Rs. 15,429 million, down from Rs. 18,742 million in Q4 2024[252]. - Profit for the period in Q4 2025 was Rs. 11,896 million, representing 13.6% of total revenues, compared to Rs. 14,038 million and 16.8% in Q4 2024[254]. - Total revenues for the nine months ended December 31, 2025, were Rs. 260,771 million, an 8% increase from Rs. 240,475 million in the same period of 2024[259]. - Net profit for the period was Rs. 40,261 million for the nine months ended December 31, 2025, representing 15.4% of total revenues, down from 17.2% in the same period of 2024[288]. Revenue Breakdown - Revenues from the Global Generics segment increased by 7% to Rs. 79,113 million, driven by growth in Emerging Markets, Europe, and India[229]. - Revenues from North America decreased by 12% to Rs. 29,644 million, attributed to lower sales prices and volumes of existing products[230]. - Revenues from Europe rose by 20% to Rs. 14,476 million, supported by new product launches and increased sales volumes[233]. - Revenues from India increased by 19% to Rs. 16,032 million, largely due to new product launches and higher sales prices[234]. - Revenues from Emerging Markets surged by 32% to Rs. 18,961 million, with 30 new products launched during the period[237]. - Revenues from the Global Generics segment for the nine months ended December 31, 2025, were Rs. 233,231 million, a 9% increase compared to Rs. 214,187 million in 2024[261]. - Revenues from the Global Generics segment in the "Rest of the World" markets increased by 10% to Rs. 16,422 million for the nine months ended December 31, 2025, compared to Rs. 14,903 million for the same period in 2024[274]. - PSAI segment revenues rose by 6% to Rs. 25,649 million for the nine months ended December 31, 2025, compared to Rs. 24,283 million for the same period in 2024[275]. Expenses - Selling, general and administrative expenses increased by 12% to Rs. 26,918 million in Q4 2025, rising as a percentage of total revenues from 28.9% to 30.8%[246]. - Selling, general and administrative expenses increased by 13% to Rs. 79,001 million for the nine months ended December 31, 2025, representing 30.3% of total revenues[279]. - Research and development expenses decreased by 8% to Rs. 6,149 million in Q4 2025, representing 7.0% of total revenues, down from 8.0% in Q4 2024[247][248]. - Research and development expenses decreased by 8% to Rs. 18,595 million for the nine months ended December 31, 2025, representing 7.1% of total revenues[280][281]. Profitability Metrics - The effective tax rate decreased to 22.9% in Q4 2025 from 25.1% in Q4 2024, with tax expense falling to Rs. 3,533 million from Rs. 4,704 million[253]. - Total gross profit was Rs. 143,573 million for the nine months ended December 31, 2025, representing a gross profit margin of 55.1%, down from 59.5% in the same period of 2024[276]. - For the three months ended December 31, 2025, the total gross profit was Rs. 46,806 million, a decrease from Rs. 49,052 million for the same period in 2024, resulting in a gross profit margin decline from 58.7% to 53.6%[244]. - The gross profit margin for the Global Generics segment decreased to 57.4% in Q4 2025 from 61.3% in Q4 2024, primarily due to price erosion and unfavorable product mix changes[244]. Product Launches and Filings - The company filed four new ANDAs with the U.S. FDA during the period, with 73 filings pending approval as of December 31, 2025[232]. - The company launched six new products in North America and ten new generic products in Europe during the three months ended December 31, 2025[231][233]. - The company launched 18 new products in North America and 31 new generic products in Europe during the nine months ended December 31, 2025[265][267]. Cash Flow and Debt - Net cash from operating activities was Rs. 41,110 million for the nine months ended December 31, 2025, compared to Rs. 24,432 million for the same period in 2024[295]. - Principal debt obligations included short-term borrowings of Rs. 50,286 million as of December 31, 2025[291]. - The company reported a net foreign exchange gain of Rs. 1,510 million for the nine months ended December 31, 2025, compared to a loss of Rs. 403 million for the same period in 2024[286]. Corporate Governance - The shares have been transferred by the Promoters to trusts as per SEBI Order dated December 31, 2024[300]. - The report includes a review by an Independent Registered Public Accounting Firm[301]. - The report was signed by Kumar Randhir Singh, Company Secretary of Dr. Reddy's Laboratories Limited[302].

Transaction Summary TrergaanrsdaicntgioNnoOnv-GerAviAewP f•inMaKncSiadlemlievaesrusrfeosu.nRdeaftlieocntaslrteepcohrnteodloagmyosuonlutstioasnsoftoSleepatdeimngbeerd3g0e,s2e0m2i5coansdaudcjtuosrtemdatnourfeafcletucrtin(ig),ae$le1c0tr0omniiclslioandvpoalucnktaagriyndge, batndprseppeacyimaletyntinmdaudsetriianlOapcptolibcearti2o0n2s5•,$a3n,d83(i2i)M3LthTeMDQec3em20b2e5r R20e2v5enaumeo1rt•iz$a1ti,o0n16pMayLmTeMntsQo3f $21002.52Cmreildliiot nAognretehme eUnSt DAdTjeursmtedLEoaBnITBDaAnd2€22.•1MmKilSlioins soene ...